Osimertinib Mesylat...

Osimertinib Mesylate CAS 1421373-66-1

Osimertinib Mesylate CAS 1421373-66-1

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: 99%
  • Payment Terms : L/C,T/T

Keywords

Osimertinib Mesylate 1421373-66-1 Osimertinib Mesylate 1421373-66-1

Quick Details

  • Appearance:White powder
  • Application:Ibrutinib is a non-receptor Bruton’s tyrosine kinase inhibitor approved for the treatment of relapsed chronic lymphocytic leukemia
  • PackAge:25kg/drum
  • ProductionCapacity:5000|Kiloliter|Week
  • Storage:Cool Dry Place
  • Transportation:

Superiority:

1. Our company is a professional production leading factory in China in pharmaceutical area of many years, our products have export.

d to USA, Greece, Spain, UK, Australia and other countries, and we have got very good feedback from our customers, we had establishe

d a long friendly relations.

2. We have many products in stock, so we can delivery quickly at the very day when receive the payment.

3. High quality, best price, first-class service, high successful delivery rate. Shipment by DHL, TNT, FedEx, HKEMS, UPS, etc

4. we have Professional packaging team, can pack the goods as customized.

Details:

Details

D-Ribose CAS#50-69-1 EINECS#200-059-4

CAS

1421373-66-1

MF


C29H37N7O5S

MW

595.71298

EINECS

200-064-1

Grade Standard

Medicine Grade, Tech Grade

Type

Auxiliaries and Other Medicinal Chemicals

Appearance

White Powder

Storage


Cool Dry Place

Application


Pharmaceutical Raw Intermediates

Description

Osimertinib is active against exon 19 deletions, exon 21 mutations, and also the exon 20 T790M mutations. It is preferentially selective for mutated EGFR, and therefore toxicity at therapeutic doses is lower than for first- and second-generation agents. Notably, osimertinib is able to cross the blood-brain barrier, making it active against disease in the CNS.

Definition

ChEBI: A methanesulfonate (mesylate) salt prepared from equimolar amounts of osimertinib and methanesulfonic acid. Used for treatment of EGFR T790M mutation positive non-small cell lung cancer.

 

Related Products

Packing & Delivery

Company Information

Wuhan hanweishi Pharmchem Co., Ltd(Hanways chempharm) is a specialized company concentrating on the R&D, production, marketing and technical service of APIs and pharmaceutical intermediates. The leading products range are APIs, Hormones, Peptides, Pharmaceutical Intermediates. Hanways main market covers more than twenties countries and areas, also we built good and long relations with many big pharmaceutical company worldwide.

 

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View